HIV-associated sensory neuropathy: risk factors and genetics (Q37988382)

26 August 2017

HIV-associated sensory neuropathy: risk factors and genetics (English)

1 reference

26 August 2017

Antonia L Wadley

2

0 references

Catherine L. Cherry

object named as

Catherine L Cherry

series ordinal

3

0 references

Peter R. Kamerman

object named as

Peter R Kamerman

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 June 2012

1 reference

Current Pain and Headache Reports

26 August 2017

1 reference

26 August 2017

16

1 reference

26 August 2017

3

1 reference

26 August 2017

226-236

1 reference

https://scigraph.springernature.com/pub.10.1007/s11916-012-0257-z

26 August 2017

0 references

cites work

The peripheral nerve complications of human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Nucleoside analogues and neuropathy in the era of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Recent advances in HIV neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

HIV-associated sensory neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Foot complications in Type 2 diabetes: an Australian population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Age and height predict neuropathy risk in patients with HIV prescribed stavudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Current perspectives on HIV-related pain and its management: insights from sub-Saharan Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Evaluating the diagnostic capacity of a single-question neuropathy screen (SQNS) in HIV positive Zambian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Treatment of human immunodeficiency virus-related polyneuropathy with 3'-azido-2',3'-dideoxythymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Role of metabolic syndrome components in HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Incident neuropathy in HIV-infected patients on HAART

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Malnutrition associated with increased risk of peripheral neuropathy in Peruvian children with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Peripheral neuropathy in HIV: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Markers of immune activation and viral load in HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

The specific disease burden of neuropathic pain: results of a French nationwide survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Assessing negative thoughts in response to pain among people with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Is there a genetic basis for health disparities in human immunodeficiency virus disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Bias, precision and heritability of self-reported and clinically measured height in Australian twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Combined genome scans for body stature in 6,602 European twins: evidence for common Caucasian loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Heritability of adult body height: a comparative study of twin cohorts in eight countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Molecular aspects of iron absorption and HFE expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Mitochondrial iron metabolism and its role in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Viral infection and iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Genome-wide screen identifies drug-induced regulation of the gene giant axonal neuropathy (Gan) in a mouse model of antiretroviral-induced painful peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-012-0257-Z

Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation

21 January 2018

1 reference

12 December 2020

Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients

1 reference

12 December 2020

Lack of correlation between length variation in the DNA polymerase gamma gene CAG repeat and lactic acidosis or neuropathy during antiretroviral treatment

1 reference

12 December 2020

Thermosensory threshold: a sensitive test of HIV associated peripheral neuropathy?

1 reference

12 December 2020

Evaluation of a clinical screening tool for HIV-associated sensory neuropathies

1 reference

12 December 2020

Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006

1 reference

12 December 2020

No Evidence of Relation Between Peripheral Neuropathy and Presence of Hemochromatosis Gene Mutations in HIV-1-Positive Patients

1 reference

12 December 2020

Genetic basis of pain variability: recent advances

1 reference

12 December 2020

Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy

1 reference

12 December 2020

The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy

1 reference

12 December 2020

Peripheral insensate neuropathy--a tall problem for US adults?

1 reference

12 December 2020

HIV-1 peripheral neuropathy and combination antiretroviral therapy

1 reference

12 December 2020

HIV neuropathy in South Africans: frequency, characteristics, and risk factors

1 reference

12 December 2020

Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients

1 reference

12 December 2020

Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya

1 reference

12 December 2020

Impaired reinnervation in HIV infection following experimental denervation

1 reference

12 December 2020

Analysis of a previously identified "pain-protective" haplotype and individual polymorphisms in the GCH1 gene in Africans with HIV-associated sensory neuropathy: a genetic association study.

1 reference

12 December 2020

Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.

1 reference

12 December 2020

10.1007/S11916-012-0257-Z

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22367397